Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PRCY - ANY BODY HAS ANY NEWS ON THESE -- Ignore unavailable to you. Want to Upgrade?

To: Chris Nevil who wrote (397)	9/21/1998 4:50:00 PM
From: Chris Nevil	Read Replies (1) \| Respond to of 670

I reached Jack Clifford and felt reassured. Things seem to be on track at ProCyte. It looks like it's just another in the endless rows of hapless victims of this sickly market, in particular malaise in their sector. The company is evaluating the best strategy to maintain the share price at levels where it would not be delisted. Tricomin and the wound care products are coming along fine. Jack mentioned that they had just returned from a conference with hair transplant doctors and Tricomin was very well received. Anyone have anything to add?